| LABORATORY RESEARCH
Noncoding RNAs that Associate with YB-1 Alter Proliferation in Prostate Cancer Cells Researchers identified a novel, abundant, 3′-modified short RNA antisense to Dicer1 (Shad1) that colocalized with YB-1 to P-bodies and stress granules. The expression of Shad1 was shown to correlate with that of YB-1 and whose inhibition leads to an increase in cell proliferation. [RNA] Abstract
Expression of Spermidine/Spermine N1-Acetyl Transferase (SSAT) in Human Prostate Tissues Is Related to Prostate Cancer Progression and Metastasis Investigators showed that in cultured human prostate cancer (PCa) cells, an activation of spermidine/spermine N1-acetyl transferase enzyme initiated a polyamine oxidation pathway and generated copious amounts of reactive oxygen species in polyamine-rich PCa cells. [Prostate] Abstract
Human and Murine Prostate Basal/Stem Cells Are Not Direct Targets of Prolactin Scientists evaluated whether prolactin (PRL) can act directly on these cells, by growing them as prostaspheres. For this, primary 3D prostasphere cultures were prepared from unfractionated cells isolated from freshly harvested human and mouse benign prostate tissues and subjected to PRL stimulation in vitro. [Gen Comp Endocrinol] Abstract
Silibinin Combination with Arsenic Strongly Inhibits Survival and Invasiveness of Human Prostate Carcinoma Cells Investigators observed that silibinin modulated the oxidative status of human prostate carcinoma DU145 cells exposed to arsenic and inhibited cell growth and survival by primarily inducing autophagy and apoptosis. [Nutr Cancer] Abstract
Vitamin D3 Potentiates the Growth Inhibitory Effects of Metformin in DU145 Human Prostate Cancer Cells Mediated by AMPK/mTOR Signaling Pathway Metformin and vitamin D3 all exhibit a strong antiproliferative action in numerous cancer cell lines including the human prostate cancer cells. Scientists showed that the combination of the two drugs had a much stronger effect on the DU145 human prostate cancer cells growth than either drug. [Clin Exp Pharmacol Physiol] Abstract
Intensified Autophagy Compromises the Efficacy of Radiotherapy against Prostate Cancer The authors investigated the autophagic activity in a series of patients with localized prostate tumors treated with radical radiotherapy, using the LC3A and the LAMP2a proteins as markers of autophagosome and lysosome cellular content, respectively. The role of autophagy on prostate cancer cell line resistance to radiation was also examined. [Biochem Biophys Res Commun] Abstract
Combined Effects of Nonylphenol and Bisphenol A on the Human Prostate Epithelial Cell Line RWPE-1 The authors analyzed the combined effects of nonylphenol and bisphenol A on the human prostate epithelial cell line RWPE-1 using two mathematical models based on the Loewe additivity theory and the Bliss independence theory. [Int J Environ Res Public Health] Full Article
CLINICAL RESEARCH
Comparative Effectiveness of Mitoxantrone plus Prednisone versus Prednisone Alone in Metastatic Castrate-Resistant Prostate Cancer after Docetaxel Failure Control arm data from two Phase III randomized control trials, SUN 1120 and TROPIC, were used to examine the efficacy of mitoxantrone plus prednisone versus prednisone alone among patients with postdocetaxel metastatic castrate-resistant prostate cancer. [Oncologist] Abstract
A Randomized Double-Blind Placebo Controlled Phase I-II Study on Clinical and Molecular Effects of Dietary Supplements in Men with Precancerous Prostatic Lesions. Chemoprevention or “Chemopromotion”? Scientists present the results of a double-blind randomized controlled trial on the pharmacokinetic, clinical, and molecular activity of dietary supplements containing lycopene, selenium, and green tea catechins in men with multifocal high grade prostatic intraepithelial neoplasia and/or atypical small acinar proliferation. [Prostate] Abstract
|